Formulation, Characterization and Gastroprotective Evaluation of a Polyherbal Suspension against Ethanol-Induced Gastric Ulcer in Wistar Rats

 

Prabhakar Singh Tiwari, Vijay Kumar Singh, Veena Devi. Singh*

Department of Pharmacy, Shri Rawatpura Sarkar University, Raipur, Chhattisgarh - 492001, India.

*Corresponding Author E-mail: veena1806@gmail.com

 

ABSTRACT:

Gastric ulcers continue to be a global health problem and are commonly treated with agents such as Omeprazole, which can lead to side effects upon long-term administration. To formulate and assess a polyherbal suspension in equal ratio of Annona squamosa, Glycyrrhiza glabra and Zingiber officinale for its gastro protective activity against ethanol-induced gastric ulcer in wistar rats along with antioxidant potential. Suspension with viscosity of 118.62 cp, a pH of 7.49 (almost neutral), and sedimentation volume of only 0.34 showed proper physical stability as well as redispersability. In the ethanol-induced ulcer model, the ulcer control group presented with a high ulcer index (11.945±0.155). Polyherbal formulation (45mg/ml) also significantly reduced the ulcer index to 4.786±0.782 (p<0.05). In addition, the formulation reduced gastric juice volume substantially (2.852±0.721mL) and increased gastric pH indicating potent anti-secretory activity like that of standard drug Omeprazole. These findings suggested that the synergistic effect of these medicinal plants provides a viable natural therapeutic approach to ameliorate oxidative stress and gastric inflammation.

 

KEYWORDS: Polyherbal formulation, Antiulcer activity, Antioxidant activity, Ethanol-induced gastric ulcer, Annona squamosa, Glycyrrhiza glabra, Zingiber officinale, Gastroprotection.

 

 


1. INTRODUCTION: 

Gastric ulcer (GU) is one of the most prevalent gastrointestinal disease, which result from the erosion of the gastric mucosal layer when aggressive factors such as gastric acid, pepsin, ethanol, Helicobacter pylori infection, non-steroidal anti-inflammatory drugs (NSAIDs), and reactive oxygen species (ROS), exceed protective components like mucus secretion and bicarbonate production or prostaglandins synthesis or mucosal blood flow and endogenous antioxidant defence systems1-2.

 

The usual medication therapy of gastric ulcer includes proton pump inhibitors, H₂-receptor antagonists, antacids as well as cytoprotective drugs. One of the drugs used extensively among them is Omeprazole3. Despite the effectiveness of these agents to mitigate gastric acidity and promote ulcer healing, longer periods of administration can have adverse reactions including headache, diarrhea, vitamin B12 deficiency and increased susceptibility to infections. Moreover, hepatoduodenal ulcers have been documented to recur substantivity due to discontinuation of therapy. Such drawbacks have prompted growing interest in other therapeutic options, especially those derived from natural products and medicinal plants that are perceived as safer with multiple pharmacological activities4. Herbs have been used for centuries in the treatment of gastrointestinal disorders in various traditional systems of medicine. Different phytochemicals of plant origin such as tannins, phenolics and saponins have demonstrated significant antiulcer5, antioxidant3, anti-inflammatory and cytoprotective Properties5. These compounds have gastroprotective effects partially mediated via inhibition of gastric acid secretion, increased mucus production and antioxidant activity and reinforcement of the gastric mucosal barrier6.

 

Some medicinal plants containing antiulcer activity such as Annona squamosa, Glycyrrhiza glabra and Zingiber officinale7. Glycyrrhiza glabra is well known for its gastroprotective effects. Furthermore, glycyrrhizin and flavonoids increase mucus secretion and saponins stimulate prostaglandin synthesis and inhibit gastric acid secretion; they play a protective role in the gastric lining, contributing to the healing of ulcers8. Such compounds are important for neutralizing reactive oxygen species and reducing gastric inflammation as well improving mucosal defensive mechanisms9.

 

Polyherbal formulations (PHFs) have been used widely in traditional medicine as they are believed to provide synergistic therapeutic effects; the combination of various medicinal plants in specified ratios is thought to offer additional benefits. These formulations, containing different phytochemical constituents act on various pathophysiological pathways simultaneously which help increase the pharmacological activity and decrease toxicity. Synergism is defined as the phenomenon in which the coaction of several bioactive compounds performs a therapeutically more effective role than what was possible with individual plant extracts10. Also, polyherbal formulations may provide a balanced therapeutic profile due to the presence of antioxidant, anti-inflammatory and cytoprotective properties in a single preparation11.

 

2. MATERIALS AND METHODS:

2.1 Drug, chemicals and reagents:

Analytical grade of the drug and all chemicals was used in this study. All other excipients surfactants, co-surfactants, gelling agents and stabilizers were obtained from Merck, USA. All solvents used for the preparation of formulations and characterization studies were analytical or HPLC grade products from accredited vendors. During the experimental procedures, either distilled or deionized water was used. All reagents and chemicals were treated and preserved under recommended manufacturer conditions to ensure stability and purity.

 

2.2 Development of polyherbal formulation:

Dissolve water and sodium benzoate in propylene glycol then a mixture of Glycyrrhiza glabra, Zingiber officinale and Annona squamosa (1:1:1) was added. However, due to the fact of CMC solubility in hot water followed up with crushing together until homogeneity, CMC-Na was mixed directly into hot water. A homogeneous mixture was obtained by mixing mucilage CMC-Na with pre-filled propylene glycol sodium benzoate (Table 1). The extract solution is gradually added to the crushed mixture. The suspension is agitated, and the triethanolamine and flavour or essence is introduced at that time until homogeneous13.

 

Table 1: Composition of polyherbal suspension

Materials

Quantity in gm/100ml

AS: GG: ZO Extracts

1:1:1 (1500:1500:1500mg)

Propylene glycol

3

Sorbitol

30

CMC-Na

1.5

Sodium benzoate

0.4

Triethanolamine

q.s

Distilled water

100ml

 

2.3 Characterization of suspension:

2.3.1 Organoleptic properties:

Color and uniformity were determined via visual observation.

 

2.3.2 Viscosity:

Measured the viscosity of the suspensions immediately after preparation using a digital viscometer. A guard leg and spindle (spindle number 2#) of a viscometer were spun in the suspension fluid at a speed of 60 revolutions per minute. Viscosity of the suspension (in poise) was measured14.

 

2.3.3 pH:

The test was carried out with the help of a pH meter. A average of three iterations of this procedure was recorded per suspension. This test allows to determine the acidity level of a preparation and consequently if it is compliant with the requirements15.

 

2.3.4 Flow rate:

The flow rate was measured according to the time needed to pipette a freshly prepared 10mL solution. This was repeated on the samples after one month of storage in which time, to study how the flow properties of formulations alters with time16.

 

2.3.5 Redispersibility:

The sedimentation volume was observed for a week and the pastes were redisperse, with the redispersibilty numbers being calculated. It was done by counting how often the cylinders were inversed when there is no more particles at bottom17.

 

2.3.6 Sedimentation volume:

We measured the volume of sediment in suspension18. The sedimentation volumes (F) of the suspensions were defined according to the following formula:

 

F= Vu/Vo

Vu is the sediment volume at time t whereas Vo represents suspension volume prior to settling.

 

2.4 Evaluation of in vivo antiulcer activity of polyherbal formulation:

2.4.1 Experimental animals:

Healthy adult Wistar rat was used as an experimental animal model for assessing in vivo antiulcer activity of the developed polyherbal formulation. Rats were selected within the 150–200g range to ensure the uniformity of physiological and metabolic status, thus reducing variability in the experimental results. All animals were from a registered animal breeding facility and were housed in clean polypropylene cages within the conventional level of laboratory condition19-20. The experimental procedures were approved by the Institute Animal Ethics Committee (IAEC), Pinnacle Biomedical Research Institute, Bhopal with approval no. PBRI/IAEC/01-12-2025/003. The animals were acclimatized with laboratory conditions for a seven-day period before the commencement of experiment. This adaptation phase facilitated the adjustment of the animals to a novel environment, minimized stress-associated physiological fluctuations, and guaranteed stabilization of biological parameters prior to gastric ulcer induction and treatment21.

 

2.4.2 Acute toxicity study:

The developed polyherbal formulation was screened for acute oral toxicity in accordance with OECD Guideline 423. The study was conducted to assess the safety profile of the formulation and to establish a safe range for future pharmacological studies. The dosing was done after fasting the healthy adult Wistar albino rats that were kept overnight with free access to only water. This dose level is selected according to OECD 423 recommendations for a substance expected to be of low toxicity22. Body weight was also assessed on day 0, day 7 and day 14 to reveal possible significant loss. Food and water intake was also recorded to detect any decrease indicating systemic toxicity. If there was no mortality or major toxic symptoms observed at 2000 mg/kg and thus the formulation to be relatively safe, a dose of 2000mg/kg or greater than it could be predicted as median lethal dose (LD₅₀) at end of the observation period which last for 14 days. In this study, the therapeutic dose for pharmacological assessment was determined as 1/10th (one-tenth) of maximum tolerated dose or LD₅₀, in consideration of current guidelines used in experimental pharmacology to balance safety and efficacy23.

 

2.4.3 Experimental design:

The animals were randomized into five subgroups as follows; Normal control (Group I) received CMC only without ulcer induction and thus provided the baseline physiological state of gastric mucosa. Group II (ulcer control): Group II was administered with ulcer-inducing agent without any therapeutic treatment; and it was used as negative control to determine the severity of gastric damage24. Group III was the standard treatment group and received Omeprazole at a dose of 20mg/kg body weight orally. For this purpose, the previously reported drug Omeprazole (a potent anti-secretory agent and gastroprotective well above the class) was used as standard to validate experimental model and compare efficacy of present polyherbal formulation. Group IV was administered the polyherbal formulation at a low dose (1/10th of estimated maximum safe dose as calculated from the acute toxicity study) while Group V received a higher dose of the formulation to evaluate therapeutic response on dosage basis. After selecting the experimental ulcer model, all treatments were therefore given orally at an appropriate dosing regimen prior to induction of the potential ulcer25.

 

2.4.4 Induction of ulcer in rats:

Test formulations were tested for anti-ulcer effectiveness in ethanol-induced stomach ulcers in Wistar albino rats. All therapies were given orally once daily for 7 days. On day 7, animals fasted for 24h with free water. Absolute ethanol (1mL/200 g body weight, p.o.) induced stomach ulcer groups II–VI. One hour after ethanol injection, animals were slaughtered and anaesthetised26.

 

2.4.5 Macroscopic Evaluation

The stomachs were promptly excised and opened along the greater curvature. Tissues were collected for analysis of the parameters of gastric juice. Stomachs were gently irrigated with normal saline to clear blood clots and debris. Ulcer lesions in the inner gastric mucosa were evaluated with a magnifier (10X). Ulcers were graded for number and severity.

 

2.4.6 Determination of ulcer index

Incidence and severity of lesion were graded using the following arbitrary scoring system27. 0 = Normal mucosa, 1 = Superficial lesions, 2 = Deep ulcers, 3 = Perforations.

 

2.4.7 Determination of pH and Volume of gastric juice

To measure gastric contents, graduated centrifuge tubes were centrifuged at 3000rpm for 10min to separate the supernatant. The centrifuged sample was quantified in mL per 100g of body mass. The pH of gastric juice was measured by diluting 1 mL with distilled water using a digital pH meter.

 

2.4.8 Determination of total acidity:

1mL of gastric juice was titrated with 0.01 N NaOH and phenolphthalein until it turned pink to determine total acidity. Dilute the mixture with 1mL distilled water and transfer to a 25mL conical flask. The volume eaten was recorded after titrating with 0.01 N NaOH until a persistent pink tint formed.

 

2.5 Oxidative markers:

2.5.1 Superoxide Dismutase (SOD):

The Superoxide Dismutase (SOD) Assay Kit reduces tetrazolium salt-produced red formazan dye to detect superoxide radicals. One unit (U) of superoxide dismutase activity dismutates 50% of superoxide radicals. To the 0.1ml sample, 1.2ml of 0.052M sodium pyrophosphate buffer, 0.1ml of phenazine methosulphate (186µM), and 0.3ml of Nitroblutetrazolium (300µM) were added. The sample solution from the previous stage was added to the final volume, totalling 750µM. Add 0.1mL glacial acetic acid and incubate 1min at 30°C. Stir in 4.0mL n-butanol after 10min. Separate butanol using centrifugation. The proportion of blank was compared to 560nm decrease and SOD inhibition. Tissue SOD unit U/mg was determined and presented28.

 

2.5.2 Lipid peroxidation (LPO):

The TBARS assay measured lipid peroxidation. To sum up, 0.2mL of the aliquot was combined with 8.1% SDS, 1.5mL of 20% acetic acid, and 1.5mL of 8.0% TBA, then diluted with 4mL of distilled water. Cool and adjust the volume to 5mL after 60 minutes on a 95°C water bath with a glass ball condenser. In 15mL pyridine, dissolve 5mL butanol.  We scraped the top layer of the mixture and measured the pink product's absorbance at 532 and 600nm with a UV-VIS Spectrophotometer (Systronic-2202). We compared the absorbance change to normal malonaldehyde tetramethyl acetal at various dosages. malondialdehyde should be measured in nmol MDA m/g tissue29.

 

2.5.3 Reduced Glutathione (GSH)

A related reaction indirectly controls GPx activity. Thus, the Glutathione Peroxidase Assay Kit detects GPx activity in the presence of GR and NADPH, which recycle the reduced glutathione created when GPx oxidises hydroperoxide. Reduced absorbance from NADPH oxidation to NADP+. 0.2mL of homogenate was mixed with 1.5mL of 20% TCA, 1.5mL of 1mM EDTA, and 10% w/v tissue homogenate in 0.1M phosphate buffer at pH 7.4. The mixture rested for 15 minutes. Centrifuge for 10minutes at 2000RPM. After transferring 400µL of the supernatant to a new tube with 1.8mL of Elman's reagent, the reagent was kept at 0-4°C in the dark. Mix with distilled water until 2mL remains; absorbance was 412nm30.

 

2.6 Statistical Analysis

The data were presented as the mean plus or minus the standard deviation (n=6). In order to compare the groups statistically, the program was used to run One-way Analysis of Variance (ANOVA) and Dunnett's multiple comparison tests. Any p-values below 0.05 were deemed to have statistical significance.

 

3. RESULTS:

3.1 Formulation and characterization of PHF:

Evaluation of homogeneity and particle size distribution for the developed polyherbal suspension revealed reproducible results. The experiment was done three times in total to improve the accuracy and consistency of the measurements. The particles were relatively uniform and controlled in size. A low standard deviation indicates that there was little variation among particles, which suggests good uniformity in the process of formulation. The distribution of many, though, was narrow and uniform. A narrow size distribution is highly desirable as it results in better physical stability and predictable sedimentation behavior. There was also uniform spreading without any aggregation of the suspension shows that the formulation is good homogeneity. No clumping or particle agglomeration is indicative for the proper mixing and stabilisation, thus indicating towards physical stability and homogeneity of the developed polyherbal suspension.

 

3.2 Evaluation of Suspension:

Organoleptic evaluation is the preliminary quality control test that determines the physical characters of a formulation with respect to human senses such as taste, color and odour. Assessments were performed on the parameters viz- colour, odour, general appearance of polyherbal suspension to check acceptability, uniformity. A lot of herbal medicines do have some natural phytoconstituents such as tannins, flavonoids and phenolic compounds which are the actual culprit responsible for speckle stain in brown in nature. Consequently, the color observed is also indicative of proper extraction of herbal bioactive and their uniform distribution into the suspension medium. The odour of the suspension was typical, reflecting herbal constituents represented by the preparation together with their natural aromatical parts. In polyherbal formulation, this typical odor is tested which shows that herbs materials have retained their desirable characteristics during the process of formulation.

 

The suspension was looks like a homogeneous liquid system without truncation. The lack of particulate impurities or phase separation suggests a stable formulation and correct blending of the ingredients. The homogeneity is also an indication that the suspension has the proper physical quality and it can process further for pharmaceutical examination. The organoleptic evaluation reflects that all physical and sensory characteristics of the polyherbal suspension were in permissible limit range, thus results indicate formulation quality acceptable.

 

3.3 Physicochemical characteristics of polyherbal suspension:

Physicochemical assessment of the prepared polyherbal suspension was performed to evaluate the stability, flow behaviour, and overall quality of formulation. These samples were characterized for viscosity, pH, flow rate, redispersibility, and sedimentation volume. Suspension viscosity of 118.62 cp was observed, which is typical viscosity level. Viscosity: correct viscosity is important for suspended particles distribution and to prevent fast sedimentation. Sufficient viscosity also allows for the formulation to be easy to dispense and administer. The pH (7.49) value of the formulation indicates that suspension is quasi neutral in nature. This pH range is favorable for most oral pharmaceutical formulations because it causes minimal irritation and maintains the stability of herbal constituents in a suspension.
                 

The flow rate 0.138 ml/sec, which indicates the acceptable flow properties of the suspension. Flow behavior is crucial so that suspension can be evenly poured out from the container and dosed properly. The redispersibility value of 3 indicates that the sediment formed during storage can be very easily redispersed by slight shaking. Redispersibility is an important quality parameter for suspensions to guarantee homogeneous distribution of active ingredients before administration.

 

Sedimentation volume was recorded 0.34 which represents ratio of the final settled volume of particles to original volume of suspension. This value reflects settling behavior that is moderately aggressive while still retaining good suspension stability. The physicochemical assessment suggests that the developed polyherbal suspension is stable, has adequate rheological properties, and inherent redispersibility profiles.

 

3.4 In vivo antiulcer activity of PHF:

3.4.1 Acute oral toxicity of Test sample PHF:

The safety profile of Polyherbal formulation upon single-dose oral administration was assessed by conducting the acute oral toxicity study as per OECD 423 Guidelines. The abbreviated stepwise dosing regimen proposed by the guideline enabled exploration of toxic manifestations and mortality using fewer animals, thus maintaining scientific rigor while adhering to ethical requirements. The lack of mortality and severe toxic signs in rats following administration of 5, 50, 300 and 2000mg/kg suggests that the extract is well tolerated at these dose levels. Minimal physical observations suggestive of mild hair loss and temporary nasal discharge occurred but progressed to serious or life-threatening conditions, implying that such effects could be stress related or reversible.

 

3.4.2 Antiulcer activity of PHF:

3.4.2.1 Determination of Ulcer Index:

Using ethanol-induced gastric ulcer models, the ulcer index was measured to assess anti-ulcer activity. The control group (Group 1) had a mean ulcer index of 5.882 ±0.482, while the standard drug group (Group 2) treated with omeprazole (20mg/kg, p.o.) had a significantly lower ulcer index (2.656±0.468, p<0.01), confirming the effectiveness of the standard anti-ulcer diet through gastric secretion inhibition. Group 3 (Annona squamosa extract: 200mg/kg, p.o.) demonstrated moderate protection against ethanol-induced stomach lesions according to ulcer index (8.781±0.013) compared to the control group. In Group 4, Zingiber officinale extract at 200 mg/kg p.o. reduced ulcer index (9.804±0.213), indicating minor gastroprotective effect (Table 3).The ulcer index decreased significantly in Group 5 treated with Glycyrrhiza glabra extract (200mg/kg, p.o.), with a considerable anti-ulcer activity comparable to the standard medicine (3.604±0.253).. Moreover, the polyherbal formulation (45mg/ml, p.o.) given to Group 6 also demonstrated a considerable protective effect with an ulcer index of 4.786±0.782 (p<0.05) suggesting strong gastroprotective potential. The findings indicate that the polyherbal formulation and Glycyrrhiza glabra extract possessed significant anti-ulcer activity, while Annona squamosa and Zingiber officinale had relatively moderate protection against ethanol-induced stomach ulcers.

 

Table 3: Gastroprotective effect of PHF on treated animals

S. No.

Groups

Treatment

Ulcer Index

(Mean + SD)

1.

Group 1

Ulcer control (received vehicle + 1ml/animal ethanol)

11.945±0.155

2.

Group 2

Standard group

(Omeprazole 20 mg/kg, p.o.)

2.656±0.468*

3.

Group 3

Treated with Annona squamosa extract

(200 mg/kg, p.o.)

8.781±0.013

4.

Group 4

Treated with Zingiber officinale (200 mg/kg, p.o.)

9.804±0.213

5.

Group 5

Treated with Glycyrrhiza glabra (200 mg/kg, p.o.)

3.604±0.253*

6.

Group 6

Treated with PHF

(45mg/ml, p.o.)

4.786±0.782*

Values are expressed as MEAN±SD at n=6, One-way ANOVA followed by Dunnett’s t-test, *p<0.05 compared to the control group 

 

3.4.2.2 Determination of Volume of gastric juice:

The group administered vehicle then 1 mL ethanol per animal (Group 1), developed the greatest volume of gastric juice, with a markedly higher concentration when compared to the other groups (6.123±0.076), indicative of pancreatitis in evoked severe gastric secretion and mucosal irritation via administration of ethanol to mice. On the other hand, standard treatment groups (Group 2) given omeprazole (20mg/kg, p.o.) showed significant decrease in volume of gastric juice (2.273±0.73), indicating the potent antisecretory and gastroprotective activity of standard anti-ulcer drug (Figure 1). In Group-3(Annona squamosa 200mg/kg, p.o), considerable gastric secretion inhibition resulted in a significant reduction in gastric juice volume (3.892±0.865) compared to the ulcogenic control group. Zingiber officinale extract (200mg/kg, p.o.) reduces gastrointestinal risk in Group 4 (3.002±0.165) compared to Annona squamosa.Group 5 treated with Glycyrrhiza glabra extract (200mg/kg, p.o.) had a higher reduction in gastric juice volume (2.751±0.351), suggesting better antisecretory and protective benefits than conventional medication groups. Additionally, the gastric juice volume was significantly deferred (2.852±0.721) in Group 6 with (45mg/ml, p.o.) of the polyherbal formulation compared to that of Indomethacin (10 mg/kg) analysed through a gastroprotective potential study performed during the course of this observation.

 

 

Figure 1: Effect of PHF on gastric volume in Ethanol induced ulcer in rats

 

3.4.2.3: Determination of pH of gastric juice:

The ulcer control group (Group 1) which received vehicle followed by 1 ml ethanol per animal had a very low gastric pH(1.835±0.173) due to high acidity and severe gastric mucosal irritation induced by ethanol administration. In fact, the standard treatment group (Group 2) using omeprazole (20mg/kg, p.o.) showed a significant increase in gastric pH (4.766±0.673, p< 0.05), confirming the notorious acid-suppressing and gastroprotective effects of the standard anti-ulcer agent.

Among the herbal treatment group, Group 3 animals receiving Annona squamosa extract (200mg/kg, p.o.) showed moderate protection as indicated by evaluation via gastric pH which reflected a significant decrease in gastric luminal acidity with mean value of 2.988±0.693 at 4 h post-feeding. Zingiber officinale extract (200 mg/kg, p.o.) treatment of Group 4 resulted in a gastric pH of 3.559±1.018 which indicates mild gastroprotective and acid-neutralizing activities. The greatest increase in gastric pH (4.976±0.784) occurred in group 5 (Glycyrrhiza glabra extract (200mg/kg, p.o.), which indicates that the use of studied dose significantly provides gradual acid neutralization and promotes greater mucosal protection against ulcerogenic agents. The maximum increase in gastric pH observed was (5.40 ±0.075, p<0.01) for the polyherbal formulation administered to group 6(45mg/ml, p.o.) confirming acid-neutralizing and gastroprotective action (Figure 2).

 

In contrast, the ulcer control group showed high gastric volume (6.123±0.076mL), extremely low pH (1.835± 0.173) and highly increased total acidity value (123.27± 3.544mEq/L), implying hypersecretion and ousting of gastric acid after ethanol administration. Acid reduces mucosal harm through heightened proteolytic activity, while also preventing epithelial restoration.

 

 

Figure 2: Effect of PHF on pH in Ethanol induced ulcer in rats

 

3.4.2.4 Total acidity determination:

The total acidity was found to be highest (123.27± 3.544) in ulcer control group (Group 1), indicated that gastric hyperacidity and damage to the gastric mucosa induced by ethanol administration is severed due to their effect of vehicle followed by 1ml ethanol per animal administration (Table 4). Group 2 was treated with omeprazole (20mg/kg, p.o) showed a significant decrease in total acidity (35.054±2.563), confirming the strong acid-suppressing activity of the standard anti-ulcer drug.

 

Among the herbal treatment groups, p.o. administration of 200 mg/kg Annona squamosa extract to Group 3 led to total acidity decrease to 59.667±3.656, showing moderate inhibition amongst gastric acid secretion groups. Likewise in Group 4, Zingiber officinale extract (200 mg/kg, p.o.) significantly decreased the total acidity (67.976±1.473). The group 5(Glycyrrhiza glabra) extract 200mg/kg p.o. was demonstrated to possess significant anti-secretory and gastroprotective activity with the values of total acidity as high as 40.114 ±1.754(p<0.01), which was markedly reduced compared to control animals. In addition, in Group 6 the total acidity decreased significantly (p<0.05) to 47.206± 1.051 with polyherbal formulation (45mg/ml; p.o.) suggesting its promising anti-ulcer and acid-reducing potential. Thus, these results indicate that the antiulcer activity of Glycyrrhiza glabra extract and polyherbal formulation may be due to the ability to possess gastric protective effect against ethanol-induced ulcer contamination. Figure 3 showing anatomy of stomachs of treated animals.


 

Table 1: Total acidity in Ethanol induced ulcer in rats

S. No.

Groups

Treatment

Ulcer Index (Mean + SD)

1.

Group 1

Ulcer control (received vehicle + 1ml/animal ethanol)

123.27±3.544

2.

Group 2

Standard group (Omeprazole 20 mg/kg, p.o.)

35.054±2.563*

3.

Group 3

Treated with Annona squamosa extract (200 mg/kg, p.o.)

59.667±3.656

4.

Group 4

Treated with Zingiber officinale (200 mg/kg, p.o.)

67.976±1.473

5.

Group 5

Treated with Glycyrrhiza glabra (200 mg/kg, p.o.)

40.114±1.754*

6.

Group 6

Treated with Polyherbal formulation (45mg/ml, p.o.)

47.206±1.051*

 


 

Inducer (Ulcer Control)

 

Standard (Omeprazole 20mg/kg)

 

Annona squamosa

 

Zingiber officinale

 

Glycyrrhiza glabra

 

Polyherbal formulation (45mg/ml, p.o.)

Figure 3: Anatomy of stomachs of treated animals

 

3.4.2.5 Oxidative stress parameters:

The ulcer control group (Group 1) exhibited the least antioxidant enzyme levels with SOD (115.5±23.538 U/ml) and GSH (2.219±0.121nmol/g tissue) (Figure 4), but higher LPO levels (66.33±5.888nmol MDA/mg tissue), revealing oxidative stress and lipid peroxidation induced by ethanol-induced gastric injury. Interestingly, the antioxidant status of patients treated with omeprazole significantly improved, as evidenced by an increase in SOD (159.1±22.890 U/ml), GSH (7.380± 0.051nmol/g tissue) and a drastic reduction in LPO (27.67±7.866 nmol MDA/mg tissue) levels compared to pre-treatment values (p<0.01) (Figure 5), thus confirming that the standard drug employed offered a protective antioxidant effect.

 

Group 3 showed a moderate antioxidant activity (SOD =101.1±9.445U/ml; LPO= 52.33± 8.042nmol MDA/mg tissue and GSH =3.688±0.118nmol/g tissue), but it did not improve significantly the ulcer control group, all other groups failed to show any significant results when data was compared with all herbal control groups. Group 4 shows much better response compared to other groups SOD (128.6±15.713 U/ml) GSH levels (4.747±0.122 nmol/g tissue) (Figure 6) and LPO (40.67±5.465 nmol MDA/mg tissue), with moderate antioxidant, protective effect in the research group of ginger extract was reduced but statistical value for increased level of SOD is not significant when comparing other treatment groups in this study.

 

Group 5 which received double impact with treatment of Glycyrrhiza glabra extract exhibited a more robust antioxidant effect with SOD (155.7±13.432 U/ml) and GSH (6.802±0.095nmol/g tissue) compared to untreated control group, whereas LPO was reduced further than other groups at highest level (30.33±7.448nmol MDA/mg tissue), where result indicated significance between different animals in the same group overall as group percentage data inside their respective standard deviation, highlighted utmost beneficial efficiency pattern (reduction) for these oxidative stress parameters among cumulative agents tested. Likewise, the polyherbal formulation (Group 6) also showed high antioxidant activity as indicated by SOD (151.0± 23.151 U/ml), LPO (32.67±5.164nmol MDA/mg tissue), GSH (6.032±0.040nmol/g tissue) (p<0.05). The results therefore showed a significant improvement in the antioxidant defense mechanisms by Glycyrrhiza glabra extract and polyherbal formulation reflected by decreased lipid peroxidation through protection of gastric tissue against oxidative stress induced by ethanol.

 

Ethanol-induced gastric mucosal injury is mediated by oxidative stress. Ethanol produces superoxide anions, hydroxyl radicals, and hydrogen peroxide that trigger lipid peroxidation and injure cell membranes. Thus, determinations of antioxidant markers like SOD, LPO and GSH gives mechanistic information for gastroprotection.

 

 

Figure 4 SOD value of treated animals

 

 

Figure 5: LPO value of treated animals

 

 

Figure 6: GSH value of treated animals

 

4. DISCUSSION:

Ethanol-induced gastric ulcer has been a well-accepted experimental model for screening of gastroprotective agents since ethanol rapidly penetrates the gastric mucosa and induces widespread hemorrhagic necrosis, vascular damage, oxidative stress and depletion of endogenous antioxidants. Indeed, in the present study the ulcer control group exhibited significant increase of ulcer index (11.945±0.155), thus confirming an absolute ethanol induced gastric mucosal damage. Ethanol inflicts direct damage to the mucosa by dissolving the mucus layer, promoting vascular permeability and ROS production, but also triggering lipid peroxidation that results in epithelial cell loss and subsequently ulcerogenous lesions.

 

It was found that polyherbal formulation decreased gastric juice secretion significantly as compared to the normal group hence it can be utilized for reduction of gastric acidity and for protection against ethanol-induced ulceration in human body.
Significant protection was also provided by polyherbal formulation (4.786±0.782), indicating mutual relationship amongst Annona squamosa, Zingiber officinale and Glycyrrhiza glabra. These findings are further supported by an evaluation of parameters of gastric secretion.

 

On the other hand, PHF caused a marked restoration of SOD levels with simultaneous reduction in oxidative stress level. These results suggest that the prepared nanoemulgel improved antioxidant defense and attenuated free radical–induced damage [32]. Elevated LPO levels detected in the inducer group (66.33±5.888 nmol MDA/mg tissue) indicate greater lipid membrane destruction due to reactive oxygen species insult [8]. The drug used to cause LPO by redox cycling therefore the standard drug and PHF formulation significantly decreased levels of LPO indicating inhibition of lipid peroxidation which imply that it stabilizing cellular membranes. Researchers showed that antioxidant-based formulations markedly reduced the lipid peroxidation and enhanced endogenous antioxidant enzyme activity levels in oxidative stress experimental models. The study of them emphasized that nano-formulated drugs increase cellular protection via better drug delivery and bioavailability33.

 

Moreover, the present study’s reduced glutathione (GSH) levels also showed significant improvement at the treatment group compared with the inducer group. GSH acts as an essential component of ROS detoxification and cellular redox balance. Treatment with PHF also increased levels of GSH which proved to be an antioxidant defense and reduced oxidative injury. It has reported similar findings, stating that antioxidant therapeutic agents significantly reinstated GSH levels in experimental models and reduced oxidative stress. These results support the mechanism of antioxidant-based therapy in reducing oxidative insult as well34.

The gel-based delivery system was a possible reason for the enhanced therapeutic effect of PHF by improving drug solubility, stability and penetration through biological barriers. Drug delivery by gel systems is reported to increase drug absorption and slow down drug residence at the target site, allowing for improved pharmacological activity35.

 

Overall, the findings of the current study are in accordance with previously reported studies showing that PHF offer superior antioxidant anti-ulcer activity and therapeutic effectiveness. Thus, the developed formulation could be promising therapeutic strategy for diseases associated with oxidative stress and gastric ulcer36.

 

5. CONCLUSION:

The study concluded that the formulation of a PHF with equal proportions of Annona squamosa, Glycyrrhiza glabra and Zingiber officinalis was effective for treating ethanol-induced gastric ulcer indicating its efficacy as a natural therapeutic agent. The physicochemical evaluations showed that the formulation has adequate physical stability, acceptable viscosity and nearly neutral pH suitable for oral administration. Study of acute toxicity confirmed its safety as well, with no mortality or severe toxic signs observed at highest dose. The ulcer index was significantly lowered and gastroprotection were enhanced by the polyherbal formulation in pharmacological studies. The formulation showed significant anti-secretory activity, reducing gastric juice volume and increasing pH levels to the standards of the drug Omeprazole.

 

6. DECLARATION:

Authors declared no conflict of interest.

 

7. AUTHOR CREDIT:

PST – writing original draft, VKS – review and editing, VDS – conceptualization.

 

8. ETHICAL STATEMENT:

The experimental procedures were approved by the Institute Animal Ethics Committee (IAEC), Pinnacle Biomedical Research Institute, Bhopal with approval no. PBRI/IAEC/01-12-2025/003.

 

9. REFERENCES:

1.      S. S. Badapanda, A. Kaur, D. Jain, and D. Bhatia. Epidemiology, Pathogenesis, and Induction of Peptic Ulcer: A Comprehensive Review.  New Emirates Med. J. 2024; 5 doi: https://doi.org/10.2174/0102506882348139241210080210.

2.      X. Xie, K. Ren, Z. Zhou, C. Dang, and H. Zhang. The global, regional and national burden of peptic ulcer disease from 1990 to 2019: a population-based study. BMC Gastroenterol. 2022; 22(1): 58 doi: 10.1186/s12876-022-02130-2.

3.      M. Andrawes, W. Andrawes, A. Das, and K. Siau. Proton Pump Inhibitors (PPIs)-An Evidence-Based Review of Indications, Efficacy,  Harms, and Deprescribing. Medicina (Kaunas). 2025; 61(9): 9 doi: 10.3390/medicina61091569.

4.      N. M. P. Maideen. Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors. Chonnam Med. J. 2023; 59(2): 115–127 doi: 10.4068/cmj.2023.59.2.115.

5.      M. Sharifi-Rad et al. Antiulcer Agents: From Plant Extracts to Phytochemicals in Healing Promotion. Molecules. 2018; 23(7): 7 doi: 10.3390/molecules23071751.

6.      W. I. Escobedo-Hinojosa, E. Gomez-Chang, K. García-Martínez, R. Guerrero Alquicira, A. Cardoso-Taketa, and I. Romero. Gastroprotective Mechanism and Ulcer Resolution Effect of Cyrtocarpa procera  Methanolic Extract on Ethanol-Induced Gastric Injury. Evid. Based. Complement. Alternat. Med. 2018: 2862706, doi: 10.1155/2018/2862706.

7.      D. K. Yadav et al. Anti-ulcer constituents of Annona squamosa twigs. Fitoterapia. 2011; 82(4): 666–675 doi: 10.1016/j.fitote.2011.02.005.

8.      G. Pastorino, L. Cornara, S. Soares, F. Rodrigues, and M. B. P. P. Oliveira. Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review. Phytother. Res. 2018; 32(12): 2323–2339 doi: 10.1002/ptr.6178.

9.      Q.-Q. Mao et al. Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe). Foods (Basel, Switzerland). 2019; 8(6). doi: 10.3390/foods8060185.

10.   S. Parasuraman, G. S. Thing, and S. A. Dhanaraj. Polyherbal formulation: Concept of ayurveda. Pharmacogn. Rev. 2014; 8(16): 73–80 doi: 10.4103/0973-7847.134229.

11.   S. Dubey and A. K. Dixit. Preclinical evidence of polyherbal formulations on wound healing: A systematic  review on research trends and perspectives. J. Ayurveda Integr. Med. 2023; 14(2): 100688 doi: 10.1016/j.jaim.2023.100688.

12.   S. Baliyan et al. Determination of Antioxidants by DPPH Radical Scavenging Activity and  Quantitative Phytochemical Analysis of Ficus religiosa. Molecules. 2022; 27(4). doi: 10.3390/molecules27041326.

13.   E. M. Costa et al. Carboxymethyl Cellulose as a Food Emulsifier: Are Its Days Numbered?. Polymers (Basel). 2023; 15(10). doi: 10.3390/polym15102408.

14.   T. Manyarara, J. Chifamba, and P. Derera. Investigation of the Suspending Properties of Dicerocaryum Zanguebarium and Adansonia Digitata Mucilage as Structured Vehicles. 2015; 4(4): 1696–1700.

15.   S. Vázquez-Blanco, L. González-Freire, M. C. Dávila-Pousa, and C. Crespo-Diz. pH determination as a quality standard for the elaboration of oral liquid  compounding formula. Farm. Hosp.  organo Of. Expr. Cient. la Soc.  Esp. Farm. Hosp. 2018;  42(6): 221–227 doi: 10.7399/fh.10932.

16.   A. Adamkowski, W. Janicki, M. Lewandowski, and E. da Costa Bortoni. Uncertainty analysis of liquid flow rate measurement with the pressure–time method. Measurement. 2021; 185: 109866 doi: https://doi.org/10.1016/j.measurement.2021.109866.

17.   S. Eraga, M. Iwuagwu, and M. Adikwu. Evaluation of the Suspending Properties of the Coprecipitate of Irvingia gabonesis Gum and Gelatin. Trop. J. Pharm. Res. 2014; 13: 843 doi: 10.4314/tjpr.v13i6.3.

18.   E. Moghimipour, A. Salimi, S. Rezaee, M. Balack, and S. Handali. Influence of flocculating agents and structural vehicles on the physical stability and rheological behavior of nitrofurantoin suspension. Jundishapur J. Nat. Pharm. Prod. 2014; 9(2): e12716 doi: 10.17795/jjnpp-12716.

19.   H. Gupta, M. Shakya, and G. Sharma. Evaluation of Anti-ulcer activity of Polyherbal preparation in Ulcerogenic Wistar rats.  Res. J. Pharm. Technol. 2022;15;3471–3474 doi: 10.52711/0974-360X.2022.00581.

20.   J. Obernier and R. Baldwin. Establishing an Appropriate Period of Acclimatization Following Transportation of Laboratory Animals.  ILAR J. 2006; 47: 364–369 doi: 10.1093/ilar.47.4.364.

21.   G. Pandey, Guidelines for experimentation as per CPCSEA. 2010. doi: 10.13140/RG.2.2.21670.75846.

22.   S. Umeshgiri, A. Nagraj, R. Meghraj, and A. K. Srinivasamurthy. Evaluation of Acute Oral Toxicity of a Polyherbal Ayurvedic Formulation in Wistar Rats as per OECD 423. Int. J. Ayurveda Pharma Res. 2025: 16–21 doi: 10.47070/ijapr.v13i5.3710.

23.   D. Smith et al. Classification and reporting of severity experienced by animals used in  scientific procedures: FELASA/ECLAM/ ESLAV Working Group report.. Lab. Anim. 2018; 52(1): 5–57 doi: 10.1177/0023677217744587.

24.   N. K. K, M. Venkateswarulu, S. B. M, D. S. M. S, and P. Pravallika. Evaluation of Antiulcer Potential of Polyherbal Preparation Against Experimentally Induced Ulcers in Rats. 2016; 8(12): 2007–2010.

25.   A. Zimmermann, J. Walters, B. Katona, P. Souney, and D. Levine. A review of omeprazole use in the treatment of acid-related disorders in children. Clin. Ther.  2001; 23: 660–79 doi: 10.1016/S0149-2918(01)80018-7.

26.   A. Robert, J. E. Nezamis, C. Lancaster, and A. J. Hanchar, “Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced  by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology. 1979; 77(3): 433–443.

27.   S. Szabo and D. Hollander. Pathways of gastrointestinal protection and repair: mechanisms of action of  sucralfate. Am. J. Med. 1989; 86(6A): 23–31 doi: 10.1016/0002-9343(89)90153-8.

28.   M. Assady, A. Farahnak, A. Golestani, and M. Esharghian. Superoxide Dismutase (SOD) Enzyme Activity Assay in Fasciola spp. Parasites and  Liver Tissue Extract. Iran. J. Parasitol. 2011; 6(4): 17–22.

29.   J. Aguilar Diaz De Leon and C. R. Borges. Evaluation of Oxidative Stress in Biological Samples Using the Thiobarbituric  Acid Reactive Substances Assay. J. Vis. Exp. 2020; 159 doi: 10.3791/61122.

30.   A. A. Sattar, A. A. Matin, M. H. Hadwan, A. M. Hadwan, and R. M. Mohammed, “Rapid and effective protocol to measure glutathione peroxidase activity,” Bull. Natl. Res. Cent. 2024; 48(1): 100 doi: 10.1186/s42269-024-01250-x.

31.   S. Bhardwaj, P. K. Gaur, and A. Tiwari. Development of Topical Nanoemulgel Using Combined Therapy for Treating Psoriasis. Assay Drug Dev. Technol. 2022; 20(1): 42–54 doi: 10.1089/adt.2021.112.

32.   P. Kangari et al. Enzymatic Antioxidant and Lipid Peroxidation Evaluation in the Newly Diagnosed  Breast Cancer Patients in Iran. Asian Pac. J. Cancer Prev. 2018; 19(12): 3511–3515 doi: 10.31557/APJCP.2018.19.12.3511.

33.   A. Ayala, M. F. Muñoz, and S. Argüelles. Lipid peroxidation: production, metabolism, and signaling mechanisms of  malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell. Longev. 2014; 2014: 360438 doi: 10.1155/2014/360438.

34.   S. K. Georgiou-Siafis and A. S. Tsiftsoglou. The Key Role of GSH in Keeping the Redox Balance in Mammalian Cells: Mechanisms  and Significance of GSH in Detoxification via Formation of Conjugates. Antioxidants (Basel, Switzerland). 2023; 12(11). doi: 10.3390/antiox12111953.

35.   D. K. Lal, B. Kumar, A. S. Saeedan, and M. N. Ansari. An Overview of Nanoemulgels for Bioavailability Enhancement in Inflammatory  Conditions via Topical Delivery. Pharmaceutics. 2023; 15(4) doi: 10.3390/pharmaceutics15041187.

36.   M. D. Chatzidaki and E. Mitsou. Advancements in Nanoemulsion-Based Drug Delivery Across Different Administration Routes. 2025. doi: 10.3390/pharmaceutics17030337.

 

 

 

 

Received on 28.04.2026      Revised on 25.05.2026

Accepted on 30.06.2026      Published on 08.08.2026

Available online from August 12, 2026

Research J. Pharmacy and Technology. 2026;19(8):3817-3826.

DOI: 10.52711/0974-360X.2026.00538

© RJPT All right reserved

 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.